Johnson & Johnson to Acquire Shockwave Medical for $13.1 Billion
Johnson & Johnson announced on April 5 that it will acquire all outstanding shares of Shockwave Medical for $335 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired. Shockwave Medical is a cardiovascular medical device company changing how calcified cardiovascular disease is treated with intravascular lithotripsy (IVL). IVL safely uses sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Shockwave has also recently acquired the Reducer, which is under clinical investigation in the United States and is CE Marked in Europe. By redistributing blood flow within the... Read More »
Halma Expands Health Tech Portfolio With a More Than $90 Million Acquisition
Halma plc has announced the acquisition of Rovers Medical Devices BV, marking a significant step in expanding its healthcare technology offerings and driving innovation. The company is being acquired for an initial cash consideration of €85 million (approximately $91.8 million USD), with additional payments of up to €6 million (about $6.5 million) pending future performance. Rovers Medical Devices BV is involved in the development, production and world-wide sales of medical devices with a focus on cell sampling devices. The company had a revenue of €12 million (about $13 million USD) for the 12 months ending December 31, 2023, according to the original deal press release. Halma is a global... Read More »
Haemonetics to Acquire Medical Device Company Attune Medical
Haemonetics Corporation announced on March 5 that it has entered into a definitive agreement to acquire privately-held Chicago-based Attune Medical. Under the terms of the agreement, Haemonetics will acquire Attune Medical for an upfront cash payment of $160 million at closing plus additional contingent consideration based on sales growth in the three years following the consummation of the transaction and the achievement of other milestones. Attune Medical is a provider of a medical device, the ensoETM® proactive esophageal cooling device, used to control the core temperature of the patient’s body. ensoETM is the only FDA-cleared temperature regulation device indicated for... Read More »
Halma Expands Health Tech Portfolio With Rovers Medical Devices
Halma plc announced on March 4 the acquisition of Rovers Medical Devices BV for an initial cash consideration of €85 million ($91.8 million USD), with additional payments of up to €6 million (about $6.5 million) pending future performance. The acquisition is expected to strengthen Halma’s market position by broadening its healthcare technology offerings. Rovers Medical Devices is involved in the development, production and world-wide sales of medical devices with a focus on cell sampling devices. The company had a revenue of €12 million (about $13 million USD) for the 12 months ending December 31, 2023, according to the original deal press release. Halma is a global group of... Read More »
Boston Scientific Posts Strong Results for Q4 2023
Boston Scientific announced its fourth quarter and full year 2023 results the morning of Wednesday, January 31. The company’s revenue for the quarter rose 15% from $3.2 billion during Q4 2022, to $3.7 billion. For the full year 2023, the company generated net sales of $14.2 billion, growing 12% over the $12.7 billion generated during full year 2022. For Q1 2024, Boston Scientific expects sales to increase 7% to 9% on an organic basis. The company’s first-quarter sales guidance is impressive as its stock hit a record high. Boston Scientific’s stock jumped a little more than 3% from $61.43 to $63.47 in afternoon trades on the stock market the day of the announcement. ... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
